Article
PET/CT in thyroid cancer - the importance of BRAF mutations.
Nuclear medicine review. Central & Eastern Europe - 1 Jan 2020
Cuccurullo Vincenzo, Di Stasio Giuseppe Danilo, Cascini Giuseppe Lucio
Abstract excerpt
Thyroid cancer (TC) represents less than 1% of all newly diagnosed malignancies. In some selected cases, with a high clinical suspicion for disease but negative I-131 scan, positron emission tomography/computed tomography (PET) with F-18-Fluorodeoxyglucose (FDG) could be helpful in the detection of disease and the definition of its extent. FDG PET/CT, better if performed after TSH stimulation analogously to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
